A randomized, double-blind, placebo-controlled study of gelesis100. A novel nonsystemic oral hydrogel for weight loss

01 Pubblicazione su rivista
Greenway Frank L., Aronne Louis J., Raben Anne, Astrup Arne, Apovian Caroline M., Hill James O., Kaplan Lee M., Fujioka Ken, Matejkova Erika, Svacina Stepan, Luzi Livio, Gnessi Lucio, Navas-Carretero Santiago, Alfredo Martinez J., Still Christopher D., Sannino Alessandro, Saponaro Cosimo, Demitri Christian, Urban Lorien E., Leider Harry, Chiquette Elaine, Ron Eyal S., Zohar Yishai, Heshmati Hassan M.
ISSN: 1930-7381

Objective: This study aims to assess the efficacy and safety of Gelesis100, a novel, nonsystemic, superabsorbent hydrogel to treat overweight or obesity. Methods: The Gelesis Loss Of Weight (GLOW) study was a 24-week, multicenter, randomized, double-blind, placebo-controlled study in patients with BMI ≥ 27 and ≤ 40 kg/m 2 and fasting plasma glucose ≥ 90 and ≤ 145 mg/dL. The co-primary end points were placebo-adjusted weight loss (superiority and 3% margin super-superiority) and at least 35% of patients in the Gelesis100 group achieving ≥ 5% weight loss. Results: Gelesis100 treatment caused greater weight loss over placebo (6.4% vs. 4.4%, P = 0.0007), achieving 2.1% superiority but not 3% super-superiority. Importantly, 59% of Gelesis100-treated patients achieved weight loss of ≥ 5%, and 27% achieved ≥ 10% versus 42% and 15% in the placebo group, respectively. Gelesis100-treated patients had twice the odds of achieving ≥ 5% and ≥ 10% weight loss versus placebo (adjusted OR: 2.0, P = 0.0008; OR: 2.1, P = 0.0107, respectively), with 5% responders having a mean weight loss of 10.2%. Patients with prediabetes or drug-naive type 2 diabetes had six times the odds of achieving ≥ 10% weight loss. Gelesis100 treatment had no apparent increased safety risks. Conclusions: Gelesis100 is a promising new nonsystemic therapy for overweight and obesity with a highly desirable safety and tolerability profile.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma